Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 2/2016

Open Access 01-08-2016 | Maternal-Fetal Medicine

Circulating maternal cortisol levels during vaginal delivery and elective cesarean section

Authors: Ylva Vladic Stjernholm, Annie Nyberg, Monica Cardell, Charlotte Höybye

Published in: Archives of Gynecology and Obstetrics | Issue 2/2016

Login to get access

Abstract

Introduction

Maternal S-cortisol levels increase throughout pregnancy and peak in the third trimester. Even higher levels are seen during the physical stress of delivery. Since analgesia for women in labor has improved, it is possible that maternal stress during labor is reduced. The aim of this study was to compare maternal S-cortisol during vaginal delivery and elective cesarean section.

Materials and methods

Twenty healthy women with spontaneous vaginal delivery and healthy women (n = 20) undergoing elective cesarean section were included in the study. S-cortisol was measured during three stages of spontaneous vaginal delivery (tvd1, tvd2 and tvd3), as well as before and after elective cesarean section (tcs1 and tcs2).

Results

In the vaginal delivery group, mean S-cortisol at tvd1 was 1325 ± 521 nmol/L, at tvd2 1559 ± 591 nmol/L and at tvd3 1368 ± 479 nmol/L. In the cesarean section group, mean S-cortisol at tcs1 was 906 ± 243 nmol/L and at tcs2 831 ± 257 nmol/L. S-cortisol was higher in the vaginal delivery group at the onset of labor as compared to the cesarean section preoperative group (p = 0.006). There were also significant differences between S-cortisol levels postpartum as compared to postoperatively (p < 0.001).

Conclusions

Maternal S-cortisol was higher during vaginal delivery compared to elective cesarean section, indicating higher stress levels. A reduction in the hydrocortisone dose at childbirth in women with adrenal insufficiency should be considered, particularly in women undergoing an elective cesarean section.
Literature
1.
go back to reference Jung C, Ho JT, Torpy DJ et al (2011) A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 96(5):1533–1540CrossRefPubMed Jung C, Ho JT, Torpy DJ et al (2011) A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 96(5):1533–1540CrossRefPubMed
2.
go back to reference Lindsay JR, Nieman LK (2005) The hypothalamic–pituitary–adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26(6):775–799CrossRefPubMed Lindsay JR, Nieman LK (2005) The hypothalamic–pituitary–adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26(6):775–799CrossRefPubMed
3.
go back to reference Mastorakos G, Ilias I (2003) Maternal and fetal hypothalamic–pituitary–adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 997:136–149CrossRefPubMed Mastorakos G, Ilias I (2003) Maternal and fetal hypothalamic–pituitary–adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 997:136–149CrossRefPubMed
4.
go back to reference Okamoto E, Takagi T, Makino T et al (1989) Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum. Horm Metab Res 21(10):566–572CrossRefPubMed Okamoto E, Takagi T, Makino T et al (1989) Immunoreactive corticotropin-releasing hormone, adrenocorticotropin and cortisol in human plasma during pregnancy and delivery and postpartum. Horm Metab Res 21(10):566–572CrossRefPubMed
5.
go back to reference Robinson BG, Emanuel RL, Frim DM et al (1998) Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 85(14):5244–5248CrossRef Robinson BG, Emanuel RL, Frim DM et al (1998) Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 85(14):5244–5248CrossRef
6.
go back to reference Scott EM, McGarrigle HH, Lachelin GC (1990) The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels. J Clin Endocrinol Metab 71(3):639–644CrossRefPubMed Scott EM, McGarrigle HH, Lachelin GC (1990) The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels. J Clin Endocrinol Metab 71(3):639–644CrossRefPubMed
7.
go back to reference Campbell EA, Linton EA, Wolfe CD et al (1987) Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 64:1054–1059CrossRefPubMed Campbell EA, Linton EA, Wolfe CD et al (1987) Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 64:1054–1059CrossRefPubMed
8.
go back to reference Hillhouse EW, Grammatopoulos DK (2002) Role of stress peptides during human pregnancy and labour. Reproduction 124(3):323–329CrossRefPubMed Hillhouse EW, Grammatopoulos DK (2002) Role of stress peptides during human pregnancy and labour. Reproduction 124(3):323–329CrossRefPubMed
9.
go back to reference Carr BR, Simpson ER (1981) Synthesis of cholesterol in the human fetus: 3-hydroxy-3-methylglutaryl coenzyme A reductase activity of liver microsomes. J Clin Endocrinol Metab 53:810–812CrossRefPubMed Carr BR, Simpson ER (1981) Synthesis of cholesterol in the human fetus: 3-hydroxy-3-methylglutaryl coenzyme A reductase activity of liver microsomes. J Clin Endocrinol Metab 53:810–812CrossRefPubMed
10.
go back to reference Goldkrand JW, Schulte RL, Messer RH (1976) Maternal and fetal plasma cortisol levels at parturition. Obstet Gynecol 47(1):41–45PubMed Goldkrand JW, Schulte RL, Messer RH (1976) Maternal and fetal plasma cortisol levels at parturition. Obstet Gynecol 47(1):41–45PubMed
11.
go back to reference Kono H, Furuhashi N, Shinkawa O et al (1987) The maternal serum cortisol levels after onset of labor. Tohoku J Exp Med 152:133–137CrossRefPubMed Kono H, Furuhashi N, Shinkawa O et al (1987) The maternal serum cortisol levels after onset of labor. Tohoku J Exp Med 152:133–137CrossRefPubMed
12.
go back to reference Ho JT, Lewis JG, O’Loughlin P et al (2007) Reduced maternal corticosteroid-binding globulin and cortisol levels in pre-eclampsia and gamete recipient pregnancies. Clin Endocrinol 66:869–877CrossRef Ho JT, Lewis JG, O’Loughlin P et al (2007) Reduced maternal corticosteroid-binding globulin and cortisol levels in pre-eclampsia and gamete recipient pregnancies. Clin Endocrinol 66:869–877CrossRef
13.
go back to reference Mukherjee K, Swyer GI (1972) Plasma cortisol and adrenocorticotrophic hormone in normal men and non-pregnant women, normal pregnant women and women with pre-eclampsia. J Obstet Gynaecol Br Commonw 79:504–512CrossRefPubMed Mukherjee K, Swyer GI (1972) Plasma cortisol and adrenocorticotrophic hormone in normal men and non-pregnant women, normal pregnant women and women with pre-eclampsia. J Obstet Gynaecol Br Commonw 79:504–512CrossRefPubMed
15.
go back to reference Ambrosi B, Barbetta L, Morricone L (2003) Diagnosis and management of Addison’s disease during pregnancy. J Endocrinol Invest 26(7):698–702CrossRefPubMed Ambrosi B, Barbetta L, Morricone L (2003) Diagnosis and management of Addison’s disease during pregnancy. J Endocrinol Invest 26(7):698–702CrossRefPubMed
16.
go back to reference Albert E, Dalaker K, Jorde R et al (1989) Addison’s disease and pregnancy. Acta Obstet Gynecol Scand 68(2):185–187CrossRefPubMed Albert E, Dalaker K, Jorde R et al (1989) Addison’s disease and pregnancy. Acta Obstet Gynecol Scand 68(2):185–187CrossRefPubMed
17.
go back to reference Lebbe M, Arlt W (2013) What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol 78(4):497–502CrossRef Lebbe M, Arlt W (2013) What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol 78(4):497–502CrossRef
18.
go back to reference van der Spuy ZM, Jacobs HS (1984) Management of endocrine disorders in pregnancy. II. Pituitary, ovarian and adrenal disease. Postgrad Med J 60:312–320CrossRefPubMedPubMedCentral van der Spuy ZM, Jacobs HS (1984) Management of endocrine disorders in pregnancy. II. Pituitary, ovarian and adrenal disease. Postgrad Med J 60:312–320CrossRefPubMedPubMedCentral
19.
go back to reference Björnsdottir S, Cnattingius S, Brandt L et al (2010) Addison’s disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Metab 95(12):5249–5257CrossRefPubMed Björnsdottir S, Cnattingius S, Brandt L et al (2010) Addison’s disease in women is a risk factor for an adverse pregnancy outcome. J Clin Endocrinol Metab 95(12):5249–5257CrossRefPubMed
20.
go back to reference Laudat MH, Cerdas S, Fournier C et al (1988) Salivary cortisol measurement: A practical approach to assess pituitary–adrenal function. J Clin Endocrinol Metab 66:343–348CrossRefPubMed Laudat MH, Cerdas S, Fournier C et al (1988) Salivary cortisol measurement: A practical approach to assess pituitary–adrenal function. J Clin Endocrinol Metab 66:343–348CrossRefPubMed
Metadata
Title
Circulating maternal cortisol levels during vaginal delivery and elective cesarean section
Authors
Ylva Vladic Stjernholm
Annie Nyberg
Monica Cardell
Charlotte Höybye
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 2/2016
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3981-x

Other articles of this Issue 2/2016

Archives of Gynecology and Obstetrics 2/2016 Go to the issue